GSK is fully committed to getting ahead of antimicrobial resistance (AMR), one of the most significant health challenges the world faces. That’s why we’re working together with partners across innovation, access and antimicrobial stewardship. We’re thrilled to announce that our Worthing manufacturing facility has become the first in the UK to achieve BSI Kitemark Certification for Minimized Risk of Antimicrobial Resistance. Achieving this rigorous international certification demonstrates our commitment to the responsible manufacturing of antibiotics and our ambition is to have all global antibiotic manufacturing sites certified by the end of 2026. Learn more: https://gsk.to/3Bc71cs #UNGA79
About us
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
- Website
-
http://www.gsk.com
External link for GSK
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Brentford, Middlesex
- Type
- Public Company
- Specialties
- Pharmaceutical products and Vaccines
Locations
Employees at GSK
Updates
-
Antimicrobial Resistance is a global challenge, with lower-income countries, particularly in Africa and Asia, shouldering a disproportionate burden. That's why we’re investing in Global Antibiotic R&D Partnership (GARDP) to ensure equitable access to antibiotics in these countries. We’ve committed €4.5m over three years, to collaborate in driving innovation and breaking down the barriers that prevent vital antibiotics from reaching those in need. Together, we're dedicated to making a positive impact on public health and improving lives worldwide. #PowerOf Antibiotics #ChangeTheTrajectory #UNGA79
-
Good health is our most precious asset. When people are well, they can learn, thrive, and contribute to their communities, no matter where they are in the world. Check out Emma's blog from her recent trip to Kenya where she saw first-hand the work we’re doing together to advance equitable responsible access to preventative interventions.
Since becoming CEO of GSK, I’ve kept a diary. Some entries are brief, some lengthy, and most barely legible but they often remind me of the inspiring work we do every single day to get ahead of disease. Hopefully from these videos of my recent visit to Nairobi and Siaya, you can see for yourself the positive impact we have by working together - uniting science, tech and most of all outstanding people to tackle the toughest challenges in healthcare. #AheadTogether
-
To solve the biggest health challenges, we must unite science, technology and talent. That’s why we invest in developing the next generation of diverse innovators. Through initiatives that offer mentoring support and hands-on science learning we provide opportunities and nurture early enthusiasm for science, technology, engineering and mathematics. Learn more: https://gsk.to/STEM Hear from Niramay, Amelia and Micaela about their passion for #STEM and ambitions for the future. 👇
-
#News for #Investors and #Media: Today, we announced that Japan’s Ministry of Health, Labour, and Welfare (MHLW) has accepted our application for one of our #bloodcancer therapies in combination with standards of care. Learn more: https://gsk.to/3B8kMJ0
-
At #ESMO24, we are showcasing the latest data from our oncology portfolio and raising awareness of the challenges and unmet needs for patients living with gynecologic cancers like ovarian cancer. Most people with ovarian cancer are diagnosed at an advanced stage – knowing the signs, symptoms and risk factors of ovarian cancer can help those who may be affected seek care sooner. Test your knowledge below.
This content isn’t available here
Access this content and more in the LinkedIn app
-
Through our research in immuno-oncology and precision medicine technologies like biomarker testing, we are pursuing innovative approaches to help doctors match patients with the cancer treatment option that is likely to be most effective for them. Learn how we are transforming the oncology research landscape to help patients live well beyond cancer: https://gsk.to/47sy2nN #ESMO24
-
Stories from patients like Carmen fuel our ongoing commitment to developing impactful treatments for people with gynaecologic cancers. Learn about the research updates we are sharing at #ESMO24: https://gsk.to/4ejRW6W
-
We believe a healthy planet is essential for human health. That’s why, Sarah and Martha, GSK engineers, environmental champions and friends are working together to support our transition to renewable energy and reduce single-use plastics at our manufacturing sites. We’re working to reduce the environmental impact of our medicines and vaccines. This will help create healthcare that’s better for people and the planet. Find out how you can make a difference with us, visit: https://gsk.to/4gn7I2u #GSKCareers #WeAreGSK
-
#News for #Investors and #Media: Today, we announced that China’s National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation for one of our #bloodcancer therapies in combination with standards of care. Learn more: https://gsk.to/3MLyvba